Specifically in B-CLL, ROR1 expression plays a pivotal role in cell survival by inhibiting apoptosis of the malignant B-cells via the activation of PI3K/AKT/mTOR and MEK/ERK pathways (36). This evidence concerns the gene ROR1 and B-cell chronic lymphocytic leukemia.